MedicarePartD.guide

A non-government resource built from CMS public data

VABRINTY 7.5 mg/.25mL Injection, Suspension, Extended Release

Also known as Leuprolide Acetate. Coverage in Delaware, DC and Maryland (CMS PDP Region 05).

Not on any stand-alone Part D formulary in Delaware, DC and Maryland

None of the 10 stand-alone Part D (PDP) plans in CMS PDP Region 05 list this drug. On one of those plans the patient would pay the full retail price, or you would need a formulary exception.

See coverage in all 39 regions →